Neumora Stock

https://neumoratx.com/BioTechFounded: 2019Funding to Date: $500MM

Neumora Therapeutics is a clinical-stage biotechnology company focused on developing neuroscience drugs.

Enterprise Value (based on primary financings)

Register for Details

For more details on financing and valuation for Neumora, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Neumora.

Register Today
Register for Details

For more details on financing and valuation for Neumora, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Other companies like Neumora in the BioTech sector

Sector
 
 
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$185MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$1.3B
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$4.89B

News

Neumora Therapeutics, Inc. (Neumora), a clinical-stage biotechnology company pioneering precision medicines for brain diseases through the integration of data science and neuroscience, announced its launch today. Neumora was founded as a response to the lack of targeted, effective medicines for brain diseases and the high failure rate that has plagued neuroscience drug development for decades.